Trending Assets
Top investors this month
Trending Assets
Top investors this month
Merck's oral pill for COVID crushes all other COVID stocks
$ABCL is down big on the news that Merck's new drug reduces hospitalization by 50%

Same with the recent ipo $HLTH which produces the home testing assay and reader/mobile app that came out at $16 rocketed to $21, and now way below the IPO price.

I would expect the market to sell off these other stocks on this news, but feels way overdone to me.

Abcellera has other programs besides COVID, and same with $HLTH testing platform.

Rob T's avatar
$21.8MFollowers
Related
Already have an account?